Bulletin
Investor Alert

New York Markets Open in:

Hoth Therapeutics Inc.

NAS: HOTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 7, 2020, 7:59 p.m.

/zigman2/quotes/202955754/composite

$

2.41

Change

-0.13 -5.12%

Volume

Volume 4,018

Quotes are delayed by 20 min

/zigman2/quotes/202955754/composite

Previous close

$ 2.44

$ 2.54

Change

+0.10 +4.10%

Day low

Day high

$2.33

$2.57

Open

52 week low

52 week high

$2.31

$7.87

Open

Annual Financials for Hoth Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 201720182019 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A --1881,2241,225
COGS excluding D&A -----
Depreciation & Amortization Expense --1881,2241,225
Depreciation --1881,2241,225
Amortization of Intangibles -----
Gross Income --(188)(1,224)(1,225)
201720182019 5-year trend
SG&A Expense --1.87M2.49M7.71M
Research & Development --586,8431.02M2.12M
Other SG&A --1.28M1.48M5.59M
Other Operating Expense -----
Unusual Expense ----(3,664)
EBIT after Unusual Expense ----(7.71M)
Non Operating Income/Expense --(144,000)-6,670
Non-Operating Interest Income ----25
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income --(2.02M)(2.5M)(7.7M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(2.02M)(2.5M)(7.7M)
Minority Interest Expense -----
Net Income --(2.02M)(2.5M)(7.7M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(2.02M)(2.5M)(7.7M)
Preferred Dividends -----
Net Income Available to Common --(2.02M)(2.5M)(7.7M)
EPS (Basic) --(0.21)(0.26)(0.84)
Basic Shares Outstanding --9.61M9.43M9.16M
EPS (Diluted) --(0.21)(0.26)(0.84)
Diluted Shares Outstanding --9.61M9.43M9.16M
EBITDA --(1.87M)(2.49M)(7.71M)
Link to MarketWatch's Slice.